Felasfa Wodajo, MD, a musculoskeletal tumor surgeon at Virginia Cancer Specialists in Fairfax, has been named future president of the Musculoskeletal Tumor Society.
Dr. Wodajo will lead the international orthopedic and oncology surgery society during its 2028-2029 term, following his upcoming service as treasurer and vice president, according to a Jan. 8 news release.
The Musculoskeletal Tumor Society is recognized for its leadership in research, education and clinical standards related to the surgical treatment of bone and soft tissue tumors.
Virginia Cancer Specialists treats the majority of sarcoma patients in Northern Virginia and operates one of the largest clinical trials programs in the Mid-Atlantic, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.